tirzepatide contraception and Birth Control Pills: When Backup May Be Needed Weight Loss Injections & Contraception

Statistical analysis A sample size of 300 participants provided an effective power of at least 96% for the two co-primary endpoints, and at least 43% for all confirmatory secondary endpoints, which were tested in a predefined hierarchical order (Supplementary Table 4)

Talk to our experts Not sure if this medication is right for you

Your healthcare provider may need to optimise your dose or consider additional diabetes medications

Patients should maintain open communication with their healthcare provider and attend scheduled follow-up appointments to track progress and address any concerns

Embody GLP-1 reports an average loss of 1.5% of body weight per week at therapeutic doses, which works out to roughly 10 to 20 pounds over 12 weeks for a 200-pound patient